What do systematic reviews say?

Summary of findings table ‐ Recombinant activated factor VII vs placebo

Recombinant human factor VII activated showed no clear difference in mortality within 5 days compared with placebo (moderate certainty).

• Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases 2012 · Cochrane Headline outcomes only
  RR 0.95 [0.36, 2.5]
  2 studies · 493 participants
  Moderate

Summary of findings table ‐ Recombinant activated factor VII vs placebo

Recombinant human factor VII activated showed no clear difference in mortality within 42 days compared with placebo (moderate certainty).

• Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases 2012 · Cochrane Headline outcomes only
  RR 1.01 [0.55, 1.87]
  2 studies · 491 participants
  Moderate

Hydrogel coated latex catheter vs silicone catheter

• Types of indwelling urinary catheters for long‐term bladder drainage in adults 2012 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 69 participants
  Low

Social cognitive theory for promotion of condom use vs no intervention

Social cognitive theory for promotion of condom use showed no clear difference in consistent condom use by FSWs with clients in the past 7‐day compared with no intervention (moderate certainty).

• Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in low‐ and… 2012 · Cochrane Headline outcomes only
  RR 0.92 [0.68, 1.24]
  1 study · 98 participants
  Moderate

Human deoxyribonuclease vs placebo

Human deoxyribonuclease showed no clear difference in clinical failure Number of children with no significant improvement… compared with placebo (low certainty).

• Interventions for primary (intrinsic) tracheomalacia in children 2012 · Cochrane Headline outcomes only
  OR 1.38 [0.37, 5.14]
  1 study · 38 participants
  Low

Human deoxyribonuclease vs placebo

• Interventions for primary (intrinsic) tracheomalacia in children 2012 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 38 participants
  Low

Intervention not reported

It is very uncertain whether the intervention changes inpatient and 30 day mortality ‐ Colon cancer (very low certainty).

• Workload and surgeon´s specialty for outcome after colorectal cancer surgery 2012 · Cochrane Headline outcomes only
  OR 0.79 [0.61, 1.02]
  3 studies · 47584 participants
  Very low

Intervention not reported

The intervention showed no clear difference in inpatient and 30 day mortality ‐ Rectal cancer (low certainty).

• Workload and surgeon´s specialty for outcome after colorectal cancer surgery 2012 · Cochrane Headline outcomes only
  OR 0.79 [0.51, 1.22]
  1 study · 1903 participants
  Low

Intervention not reported

The intervention may leads to lower inpatient and 30 day mortality ‐ Colorectal cancer (low certainty).

• Workload and surgeon´s specialty for outcome after colorectal cancer surgery 2012 · Cochrane Headline outcomes only
  OR 0.74 [0.6, 0.91]
  2 studies · 11973 participants
  Low

Intervention not reported

It is very uncertain whether the intervention changes inpatient and 30 day mortality ‐ Colorectal cancer (very low certainty).

• Workload and surgeon´s specialty for outcome after colorectal cancer surgery 2012 · Cochrane Headline outcomes only
  OR 0.98 [0.79, 1.2]
  3 studies · 77823 participants
  Very low

Intervention not reported

It is very uncertain whether the intervention changes inpatient and 30 day mortality ‐ Colon cancer (very low certainty).

• Workload and surgeon´s specialty for outcome after colorectal cancer surgery 2012 · Cochrane Headline outcomes only
  OR 0.89 [0.78, 1.01]
  7 studies · 263071 participants
  Very low

Intervention not reported

It is very uncertain whether the intervention changes inpatient and 30 day mortality ‐ Rectal cancer (very low certainty).

• Workload and surgeon´s specialty for outcome after colorectal cancer surgery 2012 · Cochrane Headline outcomes only
  OR 1.07 [0.76, 1.5]
  5 studies · 14941 participants
  Very low

Intervention not reported

The intervention showed no clear difference in early neonatal death (0 to 6 days) (moderate certainty).

• Traditional birth attendant training for improving health behaviours and pregnancy outcomes 2012 · Cochrane Headline outcomes only
  RR 0.83 [0.68, 1.01]
  3 studies · 37494 participants
  Moderate

Intervention not reported

The intervention showed no clear difference in neurological sequelae at day 28 (moderate certainty).

• Artesunate versus quinine for treating severe malaria 2012 · Cochrane Headline outcomes only
  RR 1.23 [0.74, 2.03]
  1 study · 4857 participants
  Moderate

Intervention not reported

• Artesunate versus quinine for treating severe malaria 2012 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 113 participants
  Moderate

Intervention not reported

The review found no eligible studies for this question.

• Artesunate versus quinine for treating severe malaria 2012 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Artesunate versus quinine for treating severe malaria 2012 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 113 participants
  Moderate

CBT vs no treatment

• Interventions to facilitate return to work in adults with adjustment disorders 2012 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 105 participants
  Low

Intervention not reported

The intervention showed no clear difference in mortality 30‐day (moderate certainty).

• N‐acetylcysteine for sepsis and systemic inflammatory response in adults 2012 · Cochrane Headline outcomes only
  RR 1.07 [0.8, 1.43]
  11 studies · 930 participants
  Moderate

Intervention not reported

• N‐acetylcysteine for sepsis and systemic inflammatory response in adults 2012 · Cochrane Headline outcomes only
  no estimate extracted
  19 studies · 1309 participants
  Moderate